What is a key advantage of rNPV over NPV in pharmaceutical valuation?

Question

BlackTom AI · Accepted Answer

rNPV applies success probabilities to future project cash flows, so it directly captures how risk and expected value change as a drug moves through development stages.

1) Relevant concepts
- NPV (Net Present Value): sum of projected cash flows discounted to present value at a chosen discount rate.
- Probability-adjusted NPV (rNPV): multiplies each future cash flow by the probability that the project reaches that cash flow (probability of success), then discounts. This is essentially the expected present value accounting for technical and regulatory risk that declines as development progresses.

2) Step-by-step reasoning
- In pharmaceuticals, the chance of ultimate commercialization is low early (preclinical) and increases after successful trials. NPV treats cash flows as certain; rNPV reduces each cash flow by the likelihood the program survives to generate it.
- Thus rNPV produces a value profile that rises as an asset successfully clears stages (because conditional probabilities for remaining milestones increase), reflecting reduced uncertainty.

3) Numerical illustration (intermediate steps)
- Suppose projected revenue at launch in year 5 = $100M. Discount rate = 10%. Probability of success today = 30%.
- NPV (ignoring risk): 100 / (1.1^5) = 100 / 1.61051 = $62.10M.
- rNPV: Expected payoff = 100 * 0.30 = $30M; discounted: 30 / 1.61051 = $18.63M.
- If after phase II probability rises to 70% and the program reaches that stage, rNPV (from that point) becomes 100*0.70/1.61051 = $43.44M — demonstrating value increases as risk falls.

4) Why the correct answer is correct
- The calculation method shows rNPV explicitly models decreasing risk and changing expected value as assets advance. That is its key advantage over plain NPV for drug development.

5) Why other options are incorrect
- “rNPV is simpler to calculate”: false — it requires estimating stage-specific probabilities, so it’s more complex.
- “rNPV requires less data”: false — it needs additional data (probabilities of success, stage transitions).
- “rNPV always produces higher valuations”: false — rNPV is often lower than unadjusted NPV because it discounts for failure risk; it only increases relative to prior rNPV as stage-specific probabilities improve.

6) Conclusion
The correct answer is: rNPV better reflects the decreasing risk and changing value as an asset advance through development stages (matches the provided answer).

What is a key advantage of rNPV over NPV in pharmaceutical valuation?单项选择题

类似问题

What is the primary difference between NPV and rNPV methodologies?

You own a bond that pays $64 in interest annually. The face value is $1,000 and the current market price is $1,021.61. The bond matures in 11 years. What is the yield to maturity?

Which of the following statements is CORRECT?

It will cost $9,600 to acquire an ice cream cart that is expected to produce cash inflows of $3,600 a year for three years. After the three years, the cart is expected to be worthless. What is the payback period?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单